<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">83140</article-id><article-id pub-id-type="doi">10.7554/eLife.83140</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Advance</subject></subj-group><subj-group subj-group-type="heading"><subject>Computational and Systems Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Evolutionary Biology</subject></subj-group></article-categories><title-group><article-title>Evolved bacterial resistance to the chemotherapy gemcitabine modulates its efficacy in co-cultured cells</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-198393"><name><surname>Sayin</surname><given-names>Serkan</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8776-2240</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-198372"><name><surname>Rosener</surname><given-names>Brittany</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1836-8503</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-291523"><name><surname>Li</surname><given-names>Carmen G</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-291524"><name><surname>Ho</surname><given-names>Bao</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-195354"><name><surname>Ponomarova</surname><given-names>Olga</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6331-9949</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-291525"><name><surname>Ward</surname><given-names>Doyle V</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-13890"><name><surname>Walhout</surname><given-names>Albertha JM</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5587-3608</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-182640"><name><surname>Mitchell</surname><given-names>Amir</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9376-3987</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Systems Biology</institution>, <institution>University of Massachusetts Medical School</institution>, <addr-line><named-content content-type="city">Worcester</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Department of Systems Biology</institution>, <institution>University of Massachusetts Medical School</institution>, <addr-line><named-content content-type="city">Wortcester</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Department of Microbiology and Physiological Systems</institution>, <institution>University of Massachusetts Medical School</institution>, <addr-line><named-content content-type="city">Worcester</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-61468"><name><surname>Landry</surname><given-names>Christian R</given-names></name><role>Reviewing editor</role><aff><institution>Université Laval</institution>, <country>Canada</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>amir.mitchell@umassmed.edu</email> (AM);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>03</day><month>02</month><year>2023</year></pub-date><volume>12</volume><elocation-id>e83140</elocation-id><history><date date-type="received"><day>07</day><month>09</month><year>2022</year></date><date date-type="accepted"><day>22</day><month>01</month><year>2023</year></date></history><permissions><copyright-statement>© 2023, Sayin et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Sayin et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-83140-v1.pdf"/><abstract><p>Drug metabolism by the microbiome can influence anti-cancer treatment success. We previously suggested that chemotherapies with antimicrobial activity can select for adaptations in bacterial drug metabolism that can inadvertently influence the host's chemoresistance. We demonstrated that evolved resistance against fluoropyrimidine chemotherapy lowered its efficacy in worms feeding on drug-evolved bacteria (Rosener et al., 2020). Here we examine a model system that captures local interactions that can occur in the tumor microenvironment. Gammaproteobacteria colonizing pancreatic tumors can degrade the nucleoside-analog chemotherapy gemcitabine and, in doing so, can increase the tumor's chemoresistance. Using a genetic screen in <italic>Escherichia coli</italic>, we mapped all loss-of-function mutations conferring gemcitabine resistance. Surprisingly, we infer that one third of top resistance mutations increase or decrease bacterial drug breakdown and therefore can either lower or raise the gemcitabine load in the local environment. Experiments in three <italic>E. coli</italic> strains revealed that evolved adaptation converged to inactivation of the nucleoside permease NupC, an adaptation that increased the drug burden on co-cultured cancer cells. The two studies provide complementary insights on the potential impact of microbiome adaptation to chemotherapy by showing that bacteria-drug interactions can have local and systemic influence on drug activity.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd><italic>E. coli</italic></kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R35GM133775</award-id><principal-award-recipient><name><surname>Mitchell</surname><given-names>Amir</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R01AI170722</award-id><principal-award-recipient><name><surname>Mitchell</surname><given-names>Amir</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>DK068429</award-id><principal-award-recipient><name><surname>Walhout</surname><given-names>Albertha JM</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R35GM122502</award-id><principal-award-recipient><name><surname>Walhout</surname><given-names>Albertha JM</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Barcode Sequencing and whole genome sequencing data have been deposited in NCBI SRA under the bioproject IDs PRJNA797841,PRJNA911755 and PRJNA855939.Supplementary Table 1 includes entire numerical data of the original barcoded genetic screen results and validation screen results.Supplementary Table 2 includes the all enriched and depleted pathways found in barcoded genetic screen visualized in Figure 1.Supplementary Table 3 includes the numerical data from Luria Delbruck Fluctuation experiment which is visualized on Supplementary Figure 6.Supplementary Table 4 includes the detailed annotation of genomic mutations found in all evolved clones shown in concentric circa plots at figure 4A.Supplementary Table 5 includes the list of inferred mutations from sanger sequencing files for the data used in Figure 4B.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Mitchell E</collab><collab>et al</collab></person-group><year iso-8601-date="2022">2022</year><source>E. coli barcoded deletion library screen for chemotherapeutic antimetabolite gemcitabine</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA797841">https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA797841</ext-link><comment>NCBI BioProject, PRJNA797841</comment></element-citation><element-citation id="dataset2" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Mitchell E</collab><collab>et al</collab></person-group><year iso-8601-date="2022">2022</year><source>E. coli barcoded deletion library screen for chemotherapeutic antimetabolite gemcitabine (Repeat)</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA911755">https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA911755</ext-link><comment>NCBI BioProject, PRJNA911755</comment></element-citation><element-citation id="dataset3" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Mitchell E</collab><collab>et al</collab></person-group><year iso-8601-date="2022">2022</year><source>Whole genome sequencing of gemcitabine evolved E. coli strains</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA855939">https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA855939</ext-link><comment>NCBI BioProject, PRJNA855939</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-83140-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>